Cite
HARVARD Citation
Hamer, M. et al. (2023). Safety, tolerability, and immunogenicity of the chimpanzee adenovirus type 3-vectored Marburg virus (cAd3-Marburg) vaccine in healthy adults in the USA: a first-in-human, phase 1, open-label, dose-escalation trial. Lancet. 401 (10373), pp. 294-302. [Online].